1. Home
  2. ALTI vs IMMP Comparison

ALTI vs IMMP Comparison

Compare ALTI & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTI
  • IMMP
  • Stock Information
  • Founded
  • ALTI 2020
  • IMMP 1987
  • Country
  • ALTI United States
  • IMMP Australia
  • Employees
  • ALTI N/A
  • IMMP N/A
  • Industry
  • ALTI Investment Managers
  • IMMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALTI Finance
  • IMMP Health Care
  • Exchange
  • ALTI Nasdaq
  • IMMP Nasdaq
  • Market Cap
  • ALTI 302.7M
  • IMMP 211.1M
  • IPO Year
  • ALTI N/A
  • IMMP N/A
  • Fundamental
  • Price
  • ALTI $3.29
  • IMMP $1.86
  • Analyst Decision
  • ALTI
  • IMMP Buy
  • Analyst Count
  • ALTI 0
  • IMMP 2
  • Target Price
  • ALTI N/A
  • IMMP $8.50
  • AVG Volume (30 Days)
  • ALTI 73.4K
  • IMMP 648.0K
  • Earning Date
  • ALTI 05-12-2025
  • IMMP 05-16-2025
  • Dividend Yield
  • ALTI N/A
  • IMMP N/A
  • EPS Growth
  • ALTI N/A
  • IMMP N/A
  • EPS
  • ALTI N/A
  • IMMP N/A
  • Revenue
  • ALTI $206,935,000.00
  • IMMP $3,019,249.00
  • Revenue This Year
  • ALTI $24.86
  • IMMP $11.25
  • Revenue Next Year
  • ALTI $10.74
  • IMMP $10.22
  • P/E Ratio
  • ALTI N/A
  • IMMP N/A
  • Revenue Growth
  • ALTI N/A
  • IMMP 24.11
  • 52 Week Low
  • ALTI $2.33
  • IMMP $1.32
  • 52 Week High
  • ALTI $5.45
  • IMMP $3.34
  • Technical
  • Relative Strength Index (RSI)
  • ALTI 54.28
  • IMMP 53.43
  • Support Level
  • ALTI $3.18
  • IMMP $1.44
  • Resistance Level
  • ALTI $3.50
  • IMMP $2.71
  • Average True Range (ATR)
  • ALTI 0.18
  • IMMP 0.17
  • MACD
  • ALTI -0.01
  • IMMP 0.05
  • Stochastic Oscillator
  • ALTI 47.50
  • IMMP 29.75

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

Share on Social Networks: